Table 1 General Characteristics of Study Population according to the presence/absence of hyperchloremia on PICU admission:

Age (months)

Median (min; max)

13.5 (4.7; 192.8)

14.2 (5.7; 185.8)

14 (4.7; 192.8)

Sex

Female, n (%)

29 (46.8)

47 (58)

76 (53.1)

Weight (Kg)

Median (min; max)

10 (5.5; 73)

8.4 (4.3; 50)

9 (4.3; 73)

Type of Donor

Living, n (%)

49 (79)

70 (86.4)

119 (83.2)

Primary Diagnosis, n (%)

Biliary Atresia, n (%)

32 (51.6)

58 (71.6)

90 (62.9)

Malignancies, n (%)

2 (3.2)

2 (2.5)

4 (2.8)

Metabolic Diseases, n (%)

5 (8.1)

6 (7.4)

11 (7.7)

Cholestatic Diseases, n (%)

9 (14.5)

3 (3.7)

12 (8.4)

Auto-imune hepatites, n (%)

5 (8.1)

6 (7.4)

11 (7.7)

Other, n (%)

9 (14.5)

12 (14.8)

21 (14.7)

Graft-to-Body Ratio (%)

Mean (SD)

3.1 (1.27)

3.44 (1.28)

3.29 (1.28)

Intraoperatory Fluid Balance (mL/kg)

Median (min; max)

155 (-100; +627)

136 (+ 9; +585)

147.5 (-100; +627)

PELD/MELD score

Median (min; max)

16.4 (0; 39)

15.7 (0; 40.1)

15.9 (0; 40.1)

PIM-3 predicted mortality (%)

Median (min; max)

1.28 (0.74; 3.46)

1.34 (0.78; 5.82)

1.33 (0.74; 5.82)

Baseline Serum Creatinine (mg/dL)

Median (min; max)

0.3 (0.17; 3.57)

0.17 (0.16; 0.57)

0.21 (0.16; 3.57)

Length of Stay in PICU (days)

Median (min; max)

11 (3; 92)

13 (0;45)

11 (0; 92)

Days of Mechanical Ventilation (days)

Median (min; max)

1 (0; 22)

1 (0; 28)

1 (0; 28)

Need of Renal Replacement Therapy, n (%)

Yes, n (%)

7 (11.3%)

11 (13.6%)

18 (12.6%)

Maximum sodium (mEq/L)

Mean (SD)

141.9 (3.5)

142 (3.7)

142 (3.6)

Median (min; max)

142 (134; 149)

141 (134; 154)

141 (134; 154)

Minimum sodim (mEq/L)

Mean (SD)

132.7 (5.9)

132.1 (5.6)

132.3 (5.7)

Median (min; max)

133 (119; 149)

134 (111; 140)

134 (111; 149)